[{"id":"2d8fede0-d3af-4a3f-8d61-856862f007e8","acronym":"","url":"https://clinicaltrials.gov/study/NCT03128034","created_at":"2021-01-18T15:24:33.202Z","updated_at":"2025-02-25T16:31:10.471Z","phase":"Phase 1/2","brief_title":"211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia","source_id_and_acronym":"NCT03128034","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C","pipe":"","alterations":" ","tags":["HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e sirolimus • fludarabine IV • cyclosporin A microemulsion"],"overall_status":"Recruiting","enrollment":" Enrollment 75","initiation":"Initiation: 10/24/2017","start_date":" 10/24/2017","primary_txt":" Primary completion: 06/30/2027","primary_completion_date":" 06/30/2027","study_txt":" Completion: 03/31/2029","study_completion_date":" 03/31/2029","last_update_posted":"2025-02-07"},{"id":"7c4709ee-03b2-4e5b-b8af-61df0f32ed05","acronym":"NCI-2018-01788","url":"https://clinicaltrials.gov/study/NCT03670966","created_at":"2021-01-18T18:00:29.277Z","updated_at":"2025-02-25T16:44:27.913Z","phase":"Phase 1/2","brief_title":"211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome","source_id_and_acronym":"NCT03670966 - NCI-2018-01788","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" HLA-DRB1 • HLA-B","pipe":"","alterations":" ","tags":["HLA-DRB1 • HLA-B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • sirolimus • fludarabine IV • Iomab-B (I-131-apamistamab) • cyclophosphamide intravenous"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 07/10/2019","start_date":" 07/10/2019","primary_txt":" Primary completion: 06/28/2027","primary_completion_date":" 06/28/2027","study_txt":" Completion: 03/20/2029","study_completion_date":" 03/20/2029","last_update_posted":"2025-02-05"},{"id":"103c626a-6c8d-49cd-8417-bfcea2e69b6e","acronym":"","url":"https://clinicaltrials.gov/study/NCT01921387","created_at":"2021-01-18T08:40:16.790Z","updated_at":"2024-07-02T16:36:42.380Z","phase":"Phase 1/2","brief_title":"Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies","source_id_and_acronym":"NCT01921387","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" CD34 • PTPRC","pipe":"","alterations":" ","tags":["CD34 • PTPRC"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cytarabine • etoposide IV • carmustine • melphalan • Starasid (cytarabine ocfosfate)"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 10/09/2013","start_date":" 10/09/2013","primary_txt":" Primary completion: 07/26/2017","primary_completion_date":" 07/26/2017","study_txt":" Completion: 07/26/2020","study_completion_date":" 07/26/2020","last_update_posted":"2020-08-04"},{"id":"190021fd-9fe4-49ea-ad92-1672d22fa941","acronym":"","url":"https://clinicaltrials.gov/study/NCT01300572","created_at":"2021-01-18T05:17:14.638Z","updated_at":"2024-07-02T16:36:52.676Z","phase":"Phase 1","brief_title":"Yttrium-90 Anti-CD45 Monoclonal Antibody BC8 Followed by Donor Stem Cell Transplant in Treating Patients With High-Risk AML, ALL, or MDS","source_id_and_acronym":"NCT01300572","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C","pipe":"","alterations":" ","tags":["HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e fludarabine IV • cyclosporin A microemulsion"],"overall_status":"Completed","enrollment":" Enrollment 16","initiation":"Initiation: 01/01/2012","start_date":" 01/01/2012","primary_txt":" Primary completion: 10/29/2017","primary_completion_date":" 10/29/2017","study_txt":" Completion: 11/22/2019","study_completion_date":" 11/22/2019","last_update_posted":"2019-12-10"},{"id":"f2c050cb-2528-459b-a17e-de0d65428e2f","acronym":"","url":"https://clinicaltrials.gov/study/NCT01503242","created_at":"2021-01-18T06:18:41.650Z","updated_at":"2024-07-02T16:36:52.747Z","phase":"Phase 1","brief_title":"90 Y-BC8-DOTA Monoclonal Antibody, Fludarabine Phosphate, and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma","source_id_and_acronym":"NCT01503242","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C","pipe":"","alterations":" ","tags":["HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e fludarabine IV • cyclosporin A microemulsion"],"overall_status":"Completed","enrollment":" Enrollment 15","initiation":"Initiation: 01/09/2012","start_date":" 01/09/2012","primary_txt":" Primary completion: 06/06/2017","primary_completion_date":" 06/06/2017","study_txt":" Completion: 12/06/2019","study_completion_date":" 12/06/2019","last_update_posted":"2019-12-09"},{"id":"7e54d1c6-d408-4982-8507-ad0564767413","acronym":"","url":"https://clinicaltrials.gov/study/NCT00988715","created_at":"2021-01-18T03:51:45.484Z","updated_at":"2024-07-02T16:37:18.320Z","phase":"Phase 1","brief_title":"Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome","source_id_and_acronym":"NCT00988715","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C","pipe":"","alterations":" ","tags":["HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e fludarabine IV • cyclosporin A microemulsion • BC8-SA"],"overall_status":"Completed","enrollment":" Enrollment 17","initiation":"Initiation: 04/21/2010","start_date":" 04/21/2010","primary_txt":" Primary completion: 01/01/2015","primary_completion_date":" 01/01/2015","study_txt":"","study_completion_date":"","last_update_posted":"2017-08-30"}]